Rainer Kube and his working group report in the current issue of Deutsches Arzteblatt International (Dtsch Arztebl Int 2011; 108[4]: 41-6) on new treatment strategies in patients with colon cancer. The findings…
Category: News
Researchers Have Developed A Little Bomb That Promises A Big Bang For Cancer Patients
Preliminary tests show an anti-cancer drug loosely attached to gold nanoparticles starts accumulating deep inside tumors within minutes of injection and can be activated for an effective treatment within two hours. The…
FDA Clears First Patient-Specific Implant System For Total Knee Replacement
ConforMIS has received 510(k) clearance from the U.S. Food and Drug Administration to commercially market its iTotal® CR Knee Replacement System. The iTotal CR is the only true patient-specific system available for…
How The Brain Knows What The Nose Smells
Mice know fear. And they know to fear the scent of a predator. But how do their brains quickly figure out with a sniff that a cat is nearby? It’s a complex…
Sugary snacks and lax dental hygiene put kids at risk for tooth decay
While the most prevalent focus of February is on Valentine’s sweethearts, parents are well advised to also focus on the proverbial sweet tooth – particularly when it comes to their children. That’s…
Scientists develop low cost, nanometer-sized drug to treat chronic wounds
A low cost, nanometer-sized drug to treat chronic wounds, such as diabetic foot ulcers or burns, has been developed by a group of scientists from the Hebrew University of Jerusalem, Harvard Medical…
Ornim receives FDA 510(k) clearance for non-invasive monitoring of blood flow in tissue
Ornim, Inc. is pleased to announce the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CerOx 3210F monitor. Additionally to its previous clearance for non-invasive…
Toshiba’s Aquilion ONE dynamic volume CT system to improve stroke diagnosis, treatment
Containing costs while delivering high-quality, effective care is a directive of healthcare reform. Episode-based care is part of the reform mandate and is a payment approach that reimburses on expected costs for…
Greenway University receives Colorado state approval to teach medical marijuana
Greenway University, the industry’s leading medical marijuana educational provider, has received full formal state approval from the Colorado Department of Higher Education. Greenway University marks yet another industry milestone by moving from…
Bruker launches new fully automated and fast toxin identification system
Bruker today announces the North American launch of its compact, fully automated and fast toxin identification system, called pTD™ (portable Toxin Detector), at the American Society for Microbiology (ASM) Bio-Defense and Emerging…
Reliv International launches new nutritional supplement to address entire fatigue cycle
Consumers who are fighting the fatigue cycle — physical fatigue, mental fog and stress — now have a new means of breaking that cycle. Reliv 24K, a new nutritional supplement, is the…
Psychiatric symptoms of bed breath
A study, published in the last 2010 issue of Psychotherapy and Psychosomatics by a group of researchers of the University of Torino (Italy), has explored the personality correlates and psychiatric symptoms of…
Proactive chronic care management can reduce hospital admission, readmission rates
Two Healthways Center for Health Research studies recently published in Population Health Management demonstrate that hospital admissions and readmissions can be reduced through chronic care management and proactive interventions, such as telephonic…
Unmasking Cancer At Earliest Stage With The Help Of New Induced Stem Cells
By coaxing healthy and diseased human bone marrow to become embryonic-like stem cells, a team of Wisconsin scientists has laid the groundwork for observing the onset of the blood cancer leukemia in…
Universal flu vaccine successfully tested
Scientists in Britain have successfully tested a vaccine which could work against all known flu strains, the Guardian newspaper reported on Monday. The new vaccine, developed by scientists at Oxford University, differs…